Comparison
NMN vs Krill Oil
NMN
Nicotinamide mononucleotide — NAD+ precursor. Studied for cellular aging and metabolic health.
Krill Oil
Phospholipid-bound omega-3 from Antarctic krill. Contains EPA and DHA in phospholipid form (more bioavailable than triglyceride fish oil) plus astaxanthin.
| Field | NMN | Krill Oil |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 250–1000mg | 500–2000mg |
| Half-life | — | — |
| Onset | — | — |
| Evidence | EVIDENCEB | EVIDENCEB |
| Safety | ●●●●● | ●●●●○ |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 600 | 380 |
The comparison in plain English
Auto-generated from dataNMN and Krill Oil are both in the neuroprotective category respectively. NMN Nicotinamide mononucleotide — NAD+ precursor. Krill Oil Phospholipid-bound omega-3 from Antarctic krill.
Bottom line
NMN (evidence B, safety 5/5) matches the evidence base of Krill Oil (evidence B, safety 4/5). NMN has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose NMN if
NMN is the better fit when your goal aligns with its mechanism (Direct precursor to NAD+ — one biosynthetic step closer than nicotinamide riboside, bypassing the NRK1/NRK2 enzymatic step) and the dose range (250–1000mg) suits your protocol. Half-life is —h.
Choose Krill Oil if
Krill Oil is the better fit when your goal aligns with its mechanism (Krill oil delivers omega-3 fatty acids (EPA and DHA) bound to phospholipids rather than triglycerides) and the dose range (500–2000mg) suits your protocol. Half-life is —h.